Kalaris Therapeutics, Inc.
2 Marks
Corp.
First Filed:Oct 31, 2024Latest Filed:Oct 31, 2024Address:628 Middlefield Rd, Palo Alto, CA 94301, US
Portfolio Overview
Top Classes
Class 5
PharmaceuticalsClass 42
Software, IT Services & Scientific ResearchTTAB Proceedings
No litigation activity
Top Firms
Loading...
Trademark Portfolio
2 results
(current & previous marks)
Refine by Mark/Description🔽
Filed
Registered
Last Activity

